Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis

Inflammatory Bowel Diseases

Volumn 17, Issue 7, 2011, Pages 1573-1580

  Julsgaard, Mette ^a   Nrgaard, Mette ^a   Hvas, Christian Lodberg ^a   Buck, Daniel ^a   Christensen, Lisbet Ambrosius ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

adherence; medical treatment; pregnancy; reproduction; ulcerative colitis

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; GLUCOCORTICOID; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE;

ADULT; ARTICLE; FEAR; FEMALE; FEMALE FERTILITY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; SELF CONCEPT; SELF REPORT; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; DENMARK; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RECURRENCE; SELF REPORT; YOUNG ADULT;

EID: 79958779907     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21522     Document Type: Article

References (46)

1. Jacobsen BA, Fallingborg J, Rasmussen HH, et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol. 2006; 18: 601-606. (Pubitemid 43804642)
2. Andres PG, Friedman LS., Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999; 28: 255-281, vii. (Pubitemid 29306479)
3. Bush MC, Patel S, Lapinski RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004; 15: 237-241. (Pubitemid 38686012)
4. Dominitz JA, Young JC, Boyko EJ., Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002; 97: 641-648. (Pubitemid 34245893)
5. Kane S, Lemieux N., The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2005; 100: 102-105. (Pubitemid 41623276)
6. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. Ann Intern Med. 1996; 124: 204-211.
7. Ardizzone S, Petrillo M, Molteni P, et al. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study. J Clin Gastroenterol. 1995; 21: 287-289.
8. Fockens P, Mulder CJ, Tytgat GN, et al. Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol. 1995; 7: 1025-1030. (Pubitemid 26014456)
9. Green JR, Gibson JA, Kerr GD, et al. Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. Aliment Pharmacol Ther. 1998; 12: 1207-1216. (Pubitemid 28565960)
10. Hanauer SB, Baert FJ., The management of ulcerative colitis. Annu Rev Med. 1995; 46: 497-505.
11. Kane S., Patient compliance and outcomes. Inflamm Bowel Dis. 1999; 5: 134-137.
12. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003; 114: 39-43. (Pubitemid 36126514)
13. Miner P, Hanauer S, Robinson M, et al. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci. 1995; 40: 296-304.
14. Haynes RB, Sackett DL, Taylor DW., How to detect and manage low patient compliance in chronic illness. Geriatrics. 1980; 35: 91-97.
15. Farup PG, Hovde O, Halvorsen FA, et al. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol. 1995; 30: 164-170.
16. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001; 96: 2929-2933. (Pubitemid 32959535)
17. Riley SA, Mani V, Goodman MJ, et al. Why do patients with ulcerative colitis relapse ? Gut. 1990; 31: 179-183. (Pubitemid 20092152)
18. van Hees PA, van Tongeren JH., Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol. 1982; 4: 333-336. (Pubitemid 12098750)
19. Nielsen MJ, Norgaard M, Holland-Fisher P, et al. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease. Aliment Pharmacol Ther. 2010; 32: 49-58.
20. Klassifikation af Sygdomme, 10. revision 1. udgave (International Classification of Disease, 10th rev. 1st. ed) Copenhagen: National Board of Health. 1993.
21. Knudsen LB, Olsen J., The Danish Medical Birth Registry. Dan Med Bull. 1998; 45: 320-323. (Pubitemid 28313542)
22. Vohr BR, Tyson JE, Wright LL, et al. Maternal age, multiple birth, and extremely low birth weight infants. J Pediatr. 2009; 154: 498-503.
23. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007; 102: 1417-1426. (Pubitemid 46976288)
24. Kane S, Shaya F., Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008; 53: 1020-1024. (Pubitemid 351379831)
25. D'Inca R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther. 2008; 27: 166-172. (Pubitemid 350256604)
26. Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 1233-1239.
27. Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol. 2001; 96: 2113-2116. (Pubitemid 32660906)
28. Mahadevan U, Sandborn WJ, Li DK, et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007; 133: 1106-1112. (Pubitemid 47494456)
29. Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol. 1983; 18: 735-742. (Pubitemid 13005019)
30. Kane S., Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am. 2003; 32: 323-340. (Pubitemid 36292711)
31. Hanan IM, Kirsner JB., Inflammatory bowel disease in the pregnant woman. Clin Perinatol. 1985; 12: 669-682. (Pubitemid 16239284)
32. Miller JP., Inflammatory bowel disease in pregnancy: a review. J R Soc Med. 1986; 79: 221-225. (Pubitemid 16118685)
33. Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course ? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006; 101: 1539-1545.
34. Kane SV, Accortt NA, Magowan S, et al. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment Pharmacol Ther. 2009; 29: 855-862.
35. Liu H, Kaplan AH, Wenger NS., Measuring patient adherence. Ann Intern Med. 2002; 137: 72-73.
36. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance ? Hypertension. 1980; 2: 757-764. (Pubitemid 11180123)
37. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999; 37: 846-857.
38. Horne R, Parham R, Driscoll R, et al. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 837-844.
39. Marri SR, Ahn C, Buchman AL., Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 591-599. (Pubitemid 46799644)
40. Mountifield R, Bampton P, Prosser R, et al. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009; 15: 720-725.
41. de Turah A, Norgaard M, Johansen MB, et al. Methotrexate compliance among patients with rheumatoid arthritis: the influence of disease activity, disease duration, and co-morbidity in a 10-year longitudinal study. Scand J Rheumatol. 2010; 39: 197-205.
42. Nielsen DS, Langdahl BL, Sorensen OH, et al. Persistence to medical treatment of osteoporosis in women at three different clinical settings-a historical cohort study. Scand J Public Health. 2010; 38: 502-507.
43. Fonager K, Sorensen HT, Rasmussen SN, et al. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol. 1996; 31: 154-159. (Pubitemid 26047044)
44. Kristensen J, Langhoff-Roos J, Skovgaard LT, et al. Validation of the Danish Birth Registration. J Clin Epidemiol. 1996; 49: 893-897. (Pubitemid 26283402)
45. Knudsen LB., Paritetsoplysningen i Sundhedsstyrelsens medicinske fdselsregister. (Information on parity in the medical registry of births of the National Board of Health). 1993.
46. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003; 98: 1535-1544. (Pubitemid 36875345)